|
|
Office Locations:
|
Office of Technology Commercialization
1515 Holcombe Blvd.
Houston, TX 77030
Phone: 713-745-9602
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
The Office of Technology Commercialization (OTC) is actively identifying platform level technologies suitable for start-up company formation in order to create institutional value for intellectual property derived from novel inventions made by M.D. Anderson researchers and faculty. Since 1987, OTC has been involved in the creation of eleven affiliated companies that have raised over $300 million on the strength of M.D. Anderson technologies. Four portfolio companies listed on NASDAQ have raised over $230 million and funded $25 million in sponsored research at M.D. Anderson.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
